What is Eli Health?
Eli Health is at the forefront of personalized health diagnostics, offering the Hormometer, an innovative instant hormone monitoring system. This system provides users with evidence-based insights into their hormone levels, including tests for cortisol, progesterone, and testosterone, delivering results in under 20 minutes. By enabling individuals to understand their hormonal health in real-time, Eli Health empowers users to make informed daily health decisions. The company's commitment to accuracy and accessibility is further evidenced by its portfolio of over 12 filed patents, positioning it as a leader in accessible hormone testing technology.
How much funding has Eli Health raised?
Eli Health has raised a total of $6.3M across 3 funding rounds:
Angel/Seed
$1.5M
Angel/Seed
$3.7M
Private Equity
$1.1M
Angel/Seed (2021): $1.5M with participation from Panache Ventures, Techstars, Vectr Ventures Limited, 2048 Ventures, Real Ventures, and Ramen Ventures
Angel/Seed (2023): $3.7M led by Garage Capital, Cake Ventures, and Muse Capital
Private Equity (2025): $1.1M, investors not publicly disclosed
Key Investors in Eli Health
Real Ventures
Real Ventures is a venture capital firm that backs visionary founders building innovative tech companies with large-scale positive impacts on society, providing guidance and stage-specific help for global success.
Garage Capital
Garage Capital is a venture capital firm dedicated to helping Canadian and Y Combinator startups transition from early-stage development to growth, investing in founders at the earliest stages and providing support to build category-defining businesses.
Cake Ventures
Cake Ventures is a pre-seed and seed venture capital firm that invests in companies addressing demographic changes, focusing on founders with global ambitions who create products for the evolving needs of internet users.
What's next for Eli Health?
With its recent major strategic investment and substantial total funding of $6.3M, Eli Health is poised for significant scaling and innovation. The company's focus on developing advanced hormone monitoring solutions suggests a strategic push into broader health and wellness markets. Future developments may include expanding the range of tests offered, enhancing the user experience through data analytics, and forging strategic partnerships within the healthcare ecosystem. This capital infusion will likely fuel research and development, bolster marketing efforts, and expand its operational capacity to meet growing demand for personalized health insights.
See full Eli Health company page
